Showing 191-200 of 3329 results for "".
Seeking Gender Equity in Aesthetic Medicine
https://modernaesthetics.com/ma-issues-index/2020-jan-feb/seeking-gender-equity-in-aesthetic-medicine/34861/A panel of women weighs in on the present and future of women in aesthetics.What Every Aesthetic Physician Needs to Know About Qwo
https://modernaesthetics.com/topics/injectables/what-every-aesthetic-physician-needs-to-know-about-qwo/35021/Reaching the market this spring, collagenase clostridium histolyticum-aaes is a first-in-class injectable that seeks to change the cellulite landscape.Toward Racial and Ethnic Equality in Aesthetic Practice, Part 2
https://modernaesthetics.com/topics/minimally-invasive/toward-racial-and-ethnic-equality-in-aesthetic-practice-part-2/34942/Part two of a series continues a dialogue about challenges and opportunities in aesthetic medicine.5 Things to Know About Effective Sunscreen Use
https://modernaesthetics.com/topics/skincare/5-things-to-know-about-effective-sunscreen-use/34900/Sunscreens protect from skin cancers and skin aging. Here’s what you should know when talking to aesthetic patients.Understanding and Treating Estrogen Deficient Skin: A Panel Discussion About an Entirely New Category of Skin Care
https://modernaesthetics.com/ma-supplements/2019-june-may-supplement/understanding-and-treating-estrogen-deficient-skin-a-panel-discussion-about-an-entirely-new-category-of-skin-care/33964/Biopelle, Inc. has launched Emepelle, the first and only clinically proven skin care line that safely and effectively helps address estrogen deficient skin (EDS) with revolutionary, new MEP Technology™. To coincide with the launch, a panel of leading dermatologists convened recently to discuss the pAesthetics Conference Takeaways and Survey: Mergers & Acquisitions and the Economy
https://modernaesthetics.com/ma-issues-index/2023-may-june/aesthetics-conference-takeaways-and-survey-mergers-amp-acquisitions-and-the-economy/35282/Highlights from the 2023 American Academy of Dermatology Conference and survey of strategic buyers.1 + 1 + 1 = 10: The Additive Effect of Combined Procedures
https://modernaesthetics.com/ma-issues-index/2023-may-june/1-1-1-10-the-additive-effect-of-combined-procedures/35279/Patients don’t care about the number of syringes you use—they just want to see results.Editorial Board Forum: Can We Avoid The Commoditization Of Aesthetic Medicine?
https://modernaesthetics.com/ma-issues-index/2013-jan-feb/editorial-board-forum-can-we-avoid-the-commoditization-of-aesthetic-medicine/34799/Leaders in the field of aesthetics tell how they respond to non-core competition, the surge of price negotiating patients, and the challenges of branding oneself as an expert.Toward Racial and Ethnic Equality in Aesthetic Practice
https://modernaesthetics.com/topics/practice-development/toward-racial-and-ethnic-equality-in-aesthetic-practice/34923/Part one of a series begins a dialogue about challenges and opportunities in aesthetic medicine.MATV News: ASPS Stats, Upneeq Eyedrops for Ptosis; Allergan Acquires Soliton; The Beauty Health Company
https://modernaesthetics.com/series/matv-news/matv-news-asps-stats-upneeq-eyedrops-for-ptosis-allergan-acquires-soliton-the-beauty-health-company/33633/Annual statistics from the American Society of Plastic Surgeons predict an increased demand for cosmetic plastic surgery and non-surgical procedures and Wendy Lee, MD discusses the role for RVL’s Upneeq, a non-surgical option for ptosis, in aesthetic practices. Plus, Allergan Aesthetics acquires Sol